1016PD - Bendamustine and rituximab followed by 90Y-ibritumomab tiuxetan for relapsed follicular lymphoma: A preliminary analysis of a multicenter, prospective phase II study (BRiZ2012)
| Autor: | Kanno, M., Miura, K., Masaki, Y., Tsujimura, H., Iino, M., Takizawa, J., Maeda, Y., Yamamoto, K., Tamura, S., Yoshida, A., Yagi, H., Yoshida, I., Kitazume, K., Masunari, T., Choi, I., Kakinoki, Y., Yoshino, T., Nakamura, S., Yoshida, T. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|